You are here

cato_nationaldesk_cancer

Submitted by stang on Wed, 06/07/2023 - 12:25pm
Headline: 
FDA clears Lynparza for prostate cancer treatment
Publication Date: 
Wednesday, June 7, 2023

Primary Source:

Non-Cato Author:

Type: 
new media post
Format: 
Newspaper (Online)
Nature of Mention: 
cited